Selecting and preparing the injection site Three areas of the body are appropriate for subcutaneous semaglutide injections
For people who quit semaglutide because of unbearable nausea, bloating , or constipation , this is encouraging data suggesting they may tolerate tirzepatide better
After this period, bacterial contamination risk increases and drug stability decreases
Body weight In comparisons vs placebo, tirzepatide was the most efficacious medication for lowering body weight, resulting in reductions ranging from 9.57 kg (95% CI 8.36, 10.78) with tirzepatide 15 mg to 5.27 kg (95% CI 3.98, 6.56) with tirzepatide 5 mg (Fig
- Significant gynecomastia (in men, not women) relevant only if a male family member is borrowing your medication, which they should not be